Location-Mucosal melanoma Posts on Medivizor
Navigation Menu

Location-Mucosal melanoma Posts on Medivizor

Is surgery of metastases effective after failure of modern whole-body treatments in patients with advanced melanoma?

Is surgery of metastases effective after failure of modern whole-body treatments in patients with advanced melanoma?

Posted by on Aug 22, 2021 in Melanoma | 0 comments

In a nutshell This study looked at the use of surgery for spread disease (metastases) in patients with advanced melanoma when other whole-body treatments had failed. It found that surgical removal of metastases improved the outcomes of these patients. Some background Advanced melanoma can spread to many places in the body. It is usually...

Read More

Searching for patients with high-risk melanoma to test pembrolizumab before and after surgery

Posted by on Feb 26, 2019 in Melanoma | 0 comments

In a nutshell This trial aims to test the effectiveness of pembrolizumab (Keytruda) before and after surgery in patients with high-risk melanoma. The main outcome that will be measured will be survival without cancer-related events. The details Pembrolizumab is an anti-cancer medication that targets the immune system. It helps the immune system...

Read More

Nivolumab and ipilimumab combined treatment is associated with improved survival in advanced melanoma

Nivolumab and ipilimumab combined treatment is associated with improved survival in advanced melanoma

Posted by on Oct 17, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the effect of nivolumab (Opdivo) combined with ipilimumab (Yervoy) in overall survival in the treatment of advanced melanoma. Researchers suggested that this combination is associated with an improved survival when compared to ipilimumab alone.    Some background Advanced melanoma is associated with...

Read More

A safe and effective treatment for in-transit melanoma

A safe and effective treatment for in-transit melanoma

Posted by on Aug 3, 2014 in Melanoma | 0 comments

In a nutshell The authors evaluated the efficacy and safety of intra-lesion IL-2 for in-transit cutaneous melanoma. Some background Approximately 10% of patients with locally advanced melanoma develop in-transit cutaneous metastases (melanoma deposits within the lymphatic vessels more than 2cm from the site of the primary melanoma). Eradication of...

Read More